The majority of people with Alzheimer’s disease suffer from decreased acetylcholine esterase activity and increased butyrylcholine esterase activity [95], and acetylcholinesterase and butyrylesterase inhibitors represent an effective treatment for the disease [96,97]. The gene discussed is ACHE; the disease is Alzheimer disease.